Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
Crossref DOI link: https://doi.org/10.1007/s40261-014-0253-7
Published Online: 2014-12-16
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kongnakorn, Thitima
Lanitis, Tereza
Annemans, Lieven
Thijs, Vincent
Goethals, Marnix
Marbaix, Sophie
Wautrecht, Jean-Claude
Text and Data Mining valid from 2014-12-16